top of page
it's where dermatology lives




1/2


Abrocitinib improves chronic itching conditions
New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...
John Evans
Jun 14, 20242 min read


Emerging fungal skin infections reported
Two new and highly contagious fungal infections that cause difficult-to-treat skin rashes are prompting experts to alert healthcare...
Allan Ryan
Jun 10, 20242 min read


Donations still being accepted for the 2024 Galderma Walk for Camp Liberté
Charitable donations are still being accepted for the 8th annual Galderma Walk for Camp Liberté, held on June 6, 2024. Camp Liberté is an...
John Evans
Jun 7, 20241 min read


New study supports low-dose isotretinoin for resistant rosacea
A systematic review published as a short form communication in JAAD International has found evidence that low-dose isotretinoin can be an...
Allan Ryan
Jun 3, 20242 min read


Oral contraceptives may contribute to frontal fibrosing alopecia risk
Findings from a new study suggest that taking oral contraceptives could be linked to frontal fibrosing alopecia (FFA). The study,...
John Evans
May 31, 20242 min read


Onychopapilloma a potential marker for BAP1 tumour predisposition syndrome
New findings suggest the presence of a benign nail abnormality may lead to the diagnosis of a rare inherited disorder that increases the...
John Evans
May 24, 20242 min read


Neuropeptide in blood may lead to targeted treatment for chronic itch
A new study has identified what may be the first biomarker for chronic itch. Published in Drugs in Dermatology, researchers from the...
Allan Ryan
May 6, 20242 min read


U.S. FDA issues counterfeit botulinum toxin alert
The U.S. Food and Drug Administration (FDA) has released an alert to healthcare professionals and consumers that unsafe counterfeit versions
John Evans
May 3, 20242 min read
Featured Posts


bottom of page
